Skip to content

A diagnosis of pseudo-Cushing's syndrome using dexamethason/CRH and Alprazolam

A diagnosis of pseudo-Cushing's syndrome using dexamethason/CRH and anxiolytic Alprazolam

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1021210011
Enrollment
20
Registered
2022-04-13
Start date
2022-04-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pseudo Cushing's Syndrome Glucocorticoid , Stress, dexamethasone suppression test

Interventions

In patients suspected of having Cushing's syndrome or pseudo-Cushing's syndrome, we perform two loading tests, DEX/CRH and alprazolam tests, in order to confirm the differential ability of these tes

Sponsors

Takayasu Sinobu
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: This study will be conducted in patients with both high basal ACTH and cortisol levels who have a cortisol level of >=3 mcg/dl on a 0.5 mg dexamethasone suppression test or have a midnight cortisol level of >=5 mcg/dl.

Exclusion criteria

Exclusion criteria: Those who are long-term user of steroids should be excluded. In addition, if the blood glucose of patients is consistently above 300 mg/dl, they should be excluded because dexamethasone may exacerbate hyperglycemia.

Design outcomes

Primary

MeasureTime frame
ACTH, cortisol, salivary cortisol at midnight after administering alprazolam. Early morning ACTH and cortisol the day after alprazolam oral administration followed by 0.5mg dexamethasone use. ACTH and cortisol 15 minutes later after administering dexamethasone 0.5 mg every 6 hrs for a total of 8 doses, followed by CRH loading.

Secondary

MeasureTime frame
Urinary free cortisol in the early morning after administering alprazolam (spot urine)

Contacts

Public ContactSinobu Takayasu

Hirosaki-university Hospital

stakayas@hirosaki-u.ac.jp+81-172-39-5062

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026